HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $29.85 million.

HealthEquity sees FY2016 EPS of $0.28-$0.30, versus the consensus of $0.30. HealthEquity sees FY2016 revenue of $120-124 million, versus the consensus of $123.5 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.